34 reports

  • CANCER IMMUNOTHERAPIES DRUGS MARKET, GLOBAL, COMPANIES BY COMPOUND ANNUAL
  • PIPELINE DEVELOPERS BY COMPANY TYPE, 2018

Kite Pharma Announces Positive Topline KTE-C## Data from ZUMA-## Business Wire.

  • Cancer Immunotherapy
  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • Incyte Corporation
  • ORPHAN AND RARE DERMATOLOGY DRUGS MARKET, GLOBAL, FORECAST REVENUE BY COMPANY (%), 2017-2024
  • ORPHAN AND RARE DERMATOLOGY DRUGS MARKET, GLOBAL, FORECAST MARKET

International ##: ##-## Journal of Clinical ##(##): ##-##. from: of Child Neurology; ##(##): ##-## ##(##): ## Journal of Pharmaceutics; ##(##): ##-## British Association of Dermatologists (2018).

  • Autoimmune Disease
  • Dermatological Condition
  • Dermatological Treatment
  • Pharmaceutical
  • Incyte Corporation
  • Top Collaborations of the Assignees
  • Key Player Patent Filing by Route of Administration

Global CML Market Pharmaceuticals, Pfizer, Prism Pharmaceuticals, Incyte, Otsuka Pharmaceutical. and Others.

  • Pharmaceutical
  • Therapy
  • Incyte Corporation
  • Merck & Co., Inc.
  • Novartis AG
  • for Licensing Deals Valued Above $100m
  • Strategic Consolidations

Phase II Small molecule LP-## LEO Pharma A/ S Accolade Pharmaceuticals LLC Phase II Undisclosed Undisclosed Cysteinyl Leukotriene Receptor ## (Cysteinyl Leukotriene D## Receptor or G Protein Coupled R Zafi-## Phase II Small molecule t HG## HMTMF## CYSLTR##) AQ-##

  • Dermatological Condition
  • Dermatology
  • Pharmaceutical
  • Therapy
  • Incyte Corporation
  • Clear Cell Pipeline by Companies
  • IV. RCC Drug Pipeline by Companies

RCC Market Patent Trend by Top Inventors Merck ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Pfizer ## ## ## ## ## ## ## ## ## ## ## ## ## ## Roche ## ## ## ## ## ## ## ## ## ## ## ## ## ## NIH ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Genentech ## ## ## ## ## ## ## ## ##

  • Cancer
  • Pharmaceutical
  • Renal Cancer
  • Therapy
  • Incyte Corporation
  • IDO inhibitors pipeline candidates by companies
  • ACTIVE COMPANIES: CATEGORY AND PARAMETERS

You can easily book an appointment with one online.

  • Antiviral
  • Pharmaceutical
  • Therapy
  • United States
  • Incyte Corporation
  • TOP INDUSTRY SPONSORS OF CLINICAL TRIALS IN GVHD
  • CLINICAL TRIALS - LEADING INDUSTRY SPONSORS

PIPELINE PRODUCTS - REGIONAL BREAKDOWN Stage United States Europe Japan Australia Global Pre-registration - ## ## - - Filing Rejected/ Withdrawn - ## - - - Phase III ## ## ## - ## Phase II ## ## - - ## Phase I ## ## ## ## ## Phase ## - - - - - IND/ CTA Filed -

  • Clinical Trial
  • Pharmaceutical
  • Product Initiative
  • Incyte Corporation
  • Novartis AG
  • INCYTE - 2/2

CHIA AI TANQING PHARMACEUTICAL GROUP CO CORVUS PHARMACEUTICALS - ##/ ## ID No.

  • Pharmaceutical
  • Therapy
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • Incyte Corporation
  • Source: Ariad Pharmaceuticals, Incyte Corp, CancerResearchAnalytics.com
  • Source: Ariad Pharmaceuticals, Incyte Corp, CancerReasearchAnalytics.com

“Iclusig - ponatinib - Oncology drug report - 2013-2015 analysis; 2016-2021 expectations” is a comprehensive drug report on the most controversial drug in recent times. Iclusig is the first and only drug approved for Ariad Pharmaceuticals, classified into kinase inhibitor class and falls under targeted therapy group of drugs....

  • Pharmaceutical
  • North America
  • ARIAD Pharmaceuticals, Inc.
  • Incyte Corporation
  • Otsuka Pharmaceutical Co., Ltd.
  • OTHER DRUGS IN DEVELOPMENT FOR MF, 2016
  • 9.2 COMMERCIAL BENCHMARK OF KEY PIPELINE DRUGS

OpportunityAnalyzer: Myelofibrosis - Opportunity Analysis and Forecasts to 2025 Summary Myelofibrosis (MF, also called osteomyelofibrosis) is a rare blood disorder that causes bone marrow (BM) fibrosis. MF is classified as a chronic myeloproliferative neoplasm (MPN), a group of heterogeneous hematopoietic stem cell malignancies,...

  • Pharmaceutical
  • Japan
  • United States
  • Forecast
  • Incyte Corporation
  • RTK (TRK)
  • ONGOING CLINICAL TRIALS OF EPACADOSTAT

OPDIVO IS CURRENTLY MARKETED BY ONO PHARMACEUTICAL IN JAPAN.

  • Cancer
  • Chemotherapy
  • Pharmaceutical
  • Therapy
  • Incyte Corporation
  • Incyte Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018
  • Incyte Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Summary Incyte Corp (Incyte) is a biopharmaceutical company that discovers, develops, and commercializes proprietary cancer therapeutics.The company’s lead product, Jakafi (ruxolitinib) is marketed in the US for the treatment of patients with high-risk myelofibrosis as well as patients with polycythemia vera who are intolerant...

  • Pharmaceutical
  • United States
  • Company
  • Company Operations
  • Incyte Corporation
  • 2. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
  • 2. EXECUTIVE SUMMARY

TWITTER IS ONE OF THE MOST POPULAR PLATFORMS WHEREIN THOUSANDS OF INDIVIDUALS FOLLOW SEVERAL PHARMACEUTICAL COMPANIES.

  • Arthritis
  • Clinical Trial
  • Pharmaceutical
  • Therapy
  • Incyte Corporation

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2016 Social Media Advertising Spend in China, 2016 Databook List of Figures List of Tables ##.

  • Advertising
  • Computer
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Brands pay for space on one or more of the online company' s pages to display a static or linked banner or logo.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • ID No. Name

Innate Pharma PR Oct ##, 2016 - The study enrolled ## patients.

  • Cancer Immunotherapy
  • Pharmaceutical
  • Therapy
  • AstraZeneca PLC
  • Incyte Corporation
  • SMALL MOLECULES COMPETITIVE LANDSCAPE
  • SMALL MOLECULES

Phase ## OX## antagonis t Inflamation (Atopic Dermatitis) Glenmark pharma XOMA TAB## GBR ## MONOCLONAL ANTIBODIES Monalizumab +Durvalumab MOLECULE PHASE MOA THERAPEUTIC AREA (INDICATION) COMPANY Phase ## Phase ## Lirilumab+Ni Phase ## volumab Lirilumab+Ni volumab Pha

  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Agenus Inc.
  • Incyte Corporation
  • Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
  • PARTNERSHIPS

Summary Abramson Cancer Center (Abramson) formerly Penn Medicine’s Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment of cancer.The center provides supportive care services, which include integrative medicine...

  • Health Services
  • Pharmaceutical
  • Specialty Hospital
  • United States
  • Incyte Corporation
  • 01. Executive Summary
  • 18. Vendor Landscape

It is ranked as one of the top ## companies in the Pharmaceutical industry.

  • Blood Disease
  • Pharmaceutical
  • Therapy
  • Alexion Pharmaceuticals, Inc.
  • Incyte Corporation

Pancreatic cancer

4385 5000 3900

Pharmaceuticals Policy and Law, ##, ##-##.

  • Pharmaceutical
  • European Union
  • Japan
  • United States
  • Incyte Corporation
  • 8.2 LATE-STAGE DRUGS IN CLINICAL DEVELOPMENT
  • PRODUCT PROFILE - INCB40093 (+INCB39110)

PHARMA JAPAN WEB.

  • Pharmaceutical
  • United States
  • Demand
  • Market Size
  • Incyte Corporation

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2015 Social Media Advertising Spend in China, 2015 Databook List of Figures List of Tables ##.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Digital Advertising Spend in China, 2015 Databook REFERENCE CODE: DSDB## PUBLISHED: APRIL 2015 LIST OF FIGURES LIST OF TABLES ##.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • IMMUNE CHECKPOINT INHIBITORS: DISTRIBUTION BY DRUG DEVELOPERS
  • NOVEL IMMUNE CHECKPOINT INHIBITORS PIPELINE: DISTRIBUTION BY COMPANIES

Roche NA NA AstraZeneca ## I NCT## Recruiting Kyowa Hakko Kirin Pharma, Inc.

  • Cancer Immunotherapy
  • Pharmaceutical
  • Therapy
  • Market Size
  • Incyte Corporation
  • Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Dormant Products
  • Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Dormant Products

ASTELLAS PHARMA INC.

  • Hospital
  • Pharmaceutical
  • Therapy
  • United States
  • Incyte Corporation
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018 (CONTD..3), H1 2018
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018 (CONTD..1), H1 2018

Celon Pharma SA (Celon Pharma) is an integrated pharmaceutical company which carries out research and develops new medicines.

  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Incyte Corporation
  • DORMANT PRODUCTS, H2 2018 (CONTD..3), H2 2018
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2018 (CONTD..3), H2 2018

In line with the latest amendment, Concert Pharmaceuticals has randomized the patients to receive one of three doses of CTP-## or placebo twice a day.

  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Incyte Corporation
  • IONIS PHARMACEUTICALS INC
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES

Thalassemia - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H1 2018, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape. Thalassemia is a group of inherited...

  • Blood Disease
  • Pharmaceutical
  • United States
  • Product Initiative
  • Incyte Corporation
  • AOP ORPHAN PHARMACEUTICALS AG
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2018

Essential Thrombocythemia - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Essential Thrombocythemia - Pipeline Review, H2 2018, provides an overview of the Essential Thrombocythemia (Oncology) pipeline landscape. Essential...

  • Blood Disease
  • Pathology
  • Pharmaceutical
  • Therapy
  • Incyte Corporation
  • Incyte Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Incyte Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Incyte Corp (INCY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The...

  • Pharmaceutical
  • Therapy
  • United States
  • Company Financials
  • Incyte Corporation